celebrating

20 years

of transforming the workers’ compensation pharmacy and ancillary benefits management experience

Powered by state-of-the-art technology
Supported by human-centered service
Informed by industry expertise
Inspired by a commitment to care

5 Ways We’re Innovating the Digital Experience for Claims Professionals

Claims professionals have long been the frontline of claims management – this has not changed. What has changed is just about everything else.
Read More

The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims
Read More

2021 Industry Insights Survey Report

We surveyed 600+ workers’ comp professionals on the biggest industry disruptors and priorities.
Read More

Personalize my experience

Make selections below to see articles and information related to your role and interests.
  • I am a

  • I'm interested in

FDA Approves Two Migraine Drugs and Two NSAIDs

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

Mar 2020

2020 Workers’ Comp Industry Insights Survey

Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.

Mar 2020

JAMA Compares Effectiveness of Treatment Pathways for Opioid Use Disorder

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

Mar 2020

Embracing Telehealth in Reaction to COVID-19

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.

Mar 2020

Sandy Shtab Featured in IAIABC Member Spotlight

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.

Mar 2020

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

Feb 2020

4 Regulatory Trends to Watch Out for in 2020

What will 2020 hold for marijuana acceptance, employee misclassification, formularies, and AI?

Feb 2020

WCIRB Publishes Physical Medicine Report

An analysis of 1.5 million claims found early physical therapy lowers odds of opioid use by 14%.

Feb 2020

Marijuana Bills Could Create Protections for Employment Discrimination

Testing positive for marijuana use could one day no longer prohibit employment.

Feb 2020

An Opioid Snapshot for 2020

With a flurry of opioid developments lately, what does the big picture look like?

Feb 2020

Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Jan 2020

Psilocybin for Mental Health Disorders?

Does the active ingredient in magic mushrooms have a future in mental health?

Jan 2020

MDMA Gains Steam for PTSD Treatment

Phase 3 studies are underway, and current research sees potential for MDMA in psychotherapy.

Jan 2020

Lavender Administration Shows Promise for Anxiety

A recent meta-analysis of over 100 trials and studies found lavender to significantly reduce anxiety levels.

Jan 2020


Keeping an Eye Out for CBD

With CBD products widely available and advertised for so many ailments, claimants could be using CBD without insurers knowing.

Jan 2020

New Drug Developments Impacting Comp

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Dec 2019

Questioning Costs: A Field Guide to Fee Schedules

Understand how prices are set for medical equipment and services, and how to scrutinize those costs.

Dec 2019

How Declining Opioid Use Impacts Claims and Outcomes

According to the CWCI, reduced opioid utilization from 2010-2017 saved $6.5 billion in California comp costs.

Dec 2019

Minnesota Proposes PTSD Treatment Guidelines

Beyond compensability, Minnesota considers rules for evaluation, treatment planning, acceptable psychotherapies, and more.

Dec 2019

Healthe in the Media

Workers’ comp publications cover Healthesystems content surrounding aging physicians, successful return-to-work programs, and more.

Dec 2019

Recalls Impacting Workers’ Comp

A previous gastrointestinal drug recall expands, while a new recall for an anxiety drug is issued.

Nov 2019


Rehabilitating Your Rehab Program: Better Metrics for Physical Medicine

How more dynamic data can illuminate program performance to empower care delivery

Nov 2019

HHS Publishes Opioid Tapering and Discontinuation Guideline

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Nov 2019

More States Scrutinize Gig Economy Classifications

Shortly after California made strides on employee classification for gig economy jobs, New Jersey and New York have taken action.

Nov 2019

The Economic Impact of Non-Medical Opioid Use

The Society of Actuaries published a report that claims the economic burden of the opioid epidemic was $631 billion from 2015-2018.

Nov 2019

By the Numbers

A collection of workers’ compensation facts and figures

Winter 2019/2020

State of the States

A roundup of regulatory activity around the country

Winter 2019/2020

Rehabilitating Your Rehab Program

How more dynamic data can illuminate program performance, empowering decisions for better outcomes

Winter 2019/2020

Better Care = Lower Costs

Ten tips that can help claims professionals keep patients safe and prevent costly complications

Winter 2019/2020

When Demand Exceeds Supply: Older Patients and Fewer Physicians in Workers' Comp

The looming physician shortage and how to meet the challenge in workers' comp

Winter 2019/2020

1 2 3 4 5 7 8 9 10 11 12 13 14
lockenvelopephone-handsetmenuarrow-rightcross-circle